Discontinuation of antipsychotic medication-time to rethink trial design

Lancet Psychiatry. 2020 Oct;7(10):841-842. doi: 10.1016/S2215-0366(20)30340-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Humans
  • Medication Adherence
  • Patient Dropouts*
  • Patient Selection
  • Psychotic Disorders / drug therapy*
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Research Design*

Substances

  • Antipsychotic Agents

Associated data

  • ANZCTR/12617000870358